Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODESA: Donepezil 23 mg Titration Safety in Alzheimer's
NCT02550665Phase 3Completed
- Sponsor
- Asan Medical Center
- Start
- Dec 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil in Alzheimer's disease (AD), sponsored by Asan Medical Center. Started Dec 2014; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02550665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02550665.